MovDisordV3, PascalFrancis, Corpus, bibRecord, 002478

SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

Identifieur interne : 002478 ( PascalFrancis/Corpus ); précédent : 002477; suivant : 002479

SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

Auteurs : Irene Litvan ; Kailash P. Bhatia ; David J. Burn ; Christopher G. Goetz ; Anthony E. Lang ; Ian Mckeith ; Niall Quinn ; Kapil D. Sethi ; Cliff Shults ; Gregor K. Wenning

Source :

Movement disorders [ 0885-3185 ] ; 2003.

RBID : Pascal:03-0379937

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Démence corps Lewy, Ophtalmoplégie supranucléaire, Progressif, Atrophie multisystématisée, Dégénérescence, Noyau gris central, Article synthèse, Diagnostic, Homme.

English descriptors

KwdEn :
- Basal ganglion, Degeneration, Diagnosis, Human, Lewy body dementia, Multiple system atrophy, Parkinson disease, Progressive, Review, Supranuclear ophthalmoplegia.

Abstract

As there are no biological markers for the antemortem diagnosis of degenerative parkinsonian disorders, diagnosis currently relies upon the presence and progression of clinical features and confirmation depends on neuropathology. Clinicopathologic studies have shown significant false-positive and false-negative rates for diagnosing these disorders, and misdiagnosis is especially common during the early stages of these diseases. It is important to establish a set of widely accepted diagnostic criteria for these disorders that may be applied and reproduced in a blinded fashion. This review summarizes the findings of the SIC Task Force for the study of diagnostic criteria for parkinsonian disorders in the areas of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, and corticobasal degeneration. In each of these areas, diagnosis continues to rest on clinical findings and the judicious use of ancillary studies.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 18`
A06				`@2 5`
A08	`01`	`1`	`ENG`	`@1 SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders`
A11	`01`	`1`		`@1 LITVAN (Irene)`
A11	`02`	`1`		`@1 BHATIA (Kailash P.)`
A11	`03`	`1`		`@1 BURN (David J.)`
A11	`04`	`1`		`@1 GOETZ (Christopher G.)`
A11	`05`	`1`		`@1 LANG (Anthony E.)`
A11	`06`	`1`		`@1 MCKEITH (Ian)`
A11	`07`	`1`		`@1 QUINN (Niall)`
A11	`08`	`1`		`@1 SETHI (Kapil D.)`
A11	`09`	`1`		`@1 SHULTS (Cliff)`
A11	`10`	`1`		`@1 WENNING (Gregor K.)`
A14	`01`			`@1 Movement Disorder Program, University of Louisville, Bldg A Rm 113 @2 Louisville, KY 40205 @3 USA @Z 1 aut.`
A20				`@1 467-486`
A21				`@1 2003`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000118200090010`
A44				`@0 0000 @1 © 2003 INIST-CNRS. All rights reserved.`
A45				`@0 143 ref.`
A47	`01`	`1`		`@0 03-0379937`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 As there are no biological markers for the antemortem diagnosis of degenerative parkinsonian disorders, diagnosis currently relies upon the presence and progression of clinical features and confirmation depends on neuropathology. Clinicopathologic studies have shown significant false-positive and false-negative rates for diagnosing these disorders, and misdiagnosis is especially common during the early stages of these diseases. It is important to establish a set of widely accepted diagnostic criteria for these disorders that may be applied and reproduced in a blinded fashion. This review summarizes the findings of the SIC Task Force for the study of diagnostic criteria for parkinsonian disorders in the areas of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, and corticobasal degeneration. In each of these areas, diagnosis continues to rest on clinical findings and the judicious use of ancillary studies.
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Démence corps Lewy @2 NM @5 04`
C03	`02`	`X`	`ENG`	`@0 Lewy body dementia @2 NM @5 04`
C03	`02`	`X`	`SPA`	`@0 Demencia cuerpos Lewy @2 NM @5 04`
C03	`03`	`X`	`FRE`	`@0 Ophtalmoplégie supranucléaire @5 07`
C03	`03`	`X`	`ENG`	`@0 Supranuclear ophthalmoplegia @5 07`
C03	`03`	`X`	`SPA`	`@0 Oftalmoplejía supranuclear @5 07`
C03	`04`	`X`	`FRE`	`@0 Progressif @5 08`
C03	`04`	`X`	`ENG`	`@0 Progressive @5 08`
C03	`04`	`X`	`SPA`	`@0 Progresivo @5 08`
C03	`05`	`X`	`FRE`	`@0 Atrophie multisystématisée @2 NM @5 10`
C03	`05`	`X`	`ENG`	`@0 Multiple system atrophy @2 NM @5 10`
C03	`05`	`X`	`SPA`	`@0 Atrofia multisistematizada @2 NM @5 10`
C03	`06`	`X`	`FRE`	`@0 Dégénérescence @5 13`
C03	`06`	`X`	`ENG`	`@0 Degeneration @5 13`
C03	`06`	`X`	`SPA`	`@0 Degeneración @5 13`
C03	`07`	`X`	`FRE`	`@0 Noyau gris central @5 14`
C03	`07`	`X`	`ENG`	`@0 Basal ganglion @5 14`
C03	`07`	`X`	`SPA`	`@0 Núcleo basal @5 14`
C03	`08`	`X`	`FRE`	`@0 Article synthèse @5 16`
C03	`08`	`X`	`ENG`	`@0 Review @5 16`
C03	`08`	`X`	`SPA`	`@0 Artículo síntesis @5 16`
C03	`09`	`X`	`FRE`	`@0 Diagnostic @5 17`
C03	`09`	`X`	`ENG`	`@0 Diagnosis @5 17`
C03	`09`	`X`	`SPA`	`@0 Diagnóstico @5 17`
C03	`10`	`X`	`FRE`	`@0 Homme @5 20`
C03	`10`	`X`	`ENG`	`@0 Human @5 20`
C03	`10`	`X`	`SPA`	`@0 Hombre @5 20`
C07	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`05`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`05`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`05`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
C07	`06`	`X`	`FRE`	`@0 Oeil pathologie @5 53`
C07	`06`	`X`	`ENG`	`@0 Eye disease @5 53`
C07	`06`	`X`	`SPA`	`@0 Ojo patología @5 53`
C07	`07`	`X`	`FRE`	`@0 Oculomotricité syndrome @5 54`
C07	`07`	`X`	`ENG`	`@0 Oculomotor syndrome @5 54`
C07	`07`	`X`	`SPA`	`@0 Oculomotricidad síndrome @5 54`
C07	`08`	`X`	`FRE`	`@0 Tronc cérébral syndrome @5 57`
C07	`08`	`X`	`ENG`	`@0 Brain stem syndrome @5 57`
C07	`08`	`X`	`SPA`	`@0 Tallo encefalico sindrome @5 57`
N21				`@1 265`
N82				`@1 PSI`

Format Inist (serveur)

NO :	PASCAL 03-0379937 INIST
ET :	SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
AU :	LITVAN (Irene); BHATIA (Kailash P.); BURN (David J.); GOETZ (Christopher G.); LANG (Anthony E.); MCKEITH (Ian); QUINN (Niall); SETHI (Kapil D.); SHULTS (Cliff); WENNING (Gregor K.)
AF :	Movement Disorder Program, University of Louisville, Bldg A Rm 113/Louisville, KY 40205/Etats-Unis (1 aut.)
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2003; Vol. 18; No. 5; Pp. 467-486; Bibl. 143 ref.
LA :	Anglais
EA :	As there are no biological markers for the antemortem diagnosis of degenerative parkinsonian disorders, diagnosis currently relies upon the presence and progression of clinical features and confirmation depends on neuropathology. Clinicopathologic studies have shown significant false-positive and false-negative rates for diagnosing these disorders, and misdiagnosis is especially common during the early stages of these diseases. It is important to establish a set of widely accepted diagnostic criteria for these disorders that may be applied and reproduced in a blinded fashion. This review summarizes the findings of the SIC Task Force for the study of diagnostic criteria for parkinsonian disorders in the areas of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, and corticobasal degeneration. In each of these areas, diagnosis continues to rest on clinical findings and the judicious use of ancillary studies.
CC :	002B17G
FD :	Parkinson maladie; Démence corps Lewy; Ophtalmoplégie supranucléaire; Progressif; Atrophie multisystématisée; Dégénérescence; Noyau gris central; Article synthèse; Diagnostic; Homme
FG :	Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Oeil pathologie; Oculomotricité syndrome; Tronc cérébral syndrome
ED :	Parkinson disease; Lewy body dementia; Supranuclear ophthalmoplegia; Progressive; Multiple system atrophy; Degeneration; Basal ganglion; Review; Diagnosis; Human
EG :	Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Eye disease; Oculomotor syndrome; Brain stem syndrome
SD :	Parkinson enfermedad; Demencia cuerpos Lewy; Oftalmoplejía supranuclear; Progresivo; Atrofia multisistematizada; Degeneración; Núcleo basal; Artículo síntesis; Diagnóstico; Hombre
LO :	INIST-20953.354000118200090010
ID :	03-0379937

Links to Exploration step

Pascal:03-0379937

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders</title>
<author><name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name>
<affiliation><inist:fA14 i1="01"><s1>Movement Disorder Program, University of Louisville, Bldg A Rm 113</s1>
<s2>Louisville, KY 40205</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
</author>
<author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
</author>
<author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
</author>
<author><name sortKey="Mckeith, Ian" sort="Mckeith, Ian" uniqKey="Mckeith I" first="Ian" last="Mckeith">Ian Mckeith</name>
</author>
<author><name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name>
</author>
<author><name sortKey="Sethi, Kapil D" sort="Sethi, Kapil D" uniqKey="Sethi K" first="Kapil D." last="Sethi">Kapil D. Sethi</name>
</author>
<author><name sortKey="Shults, Cliff" sort="Shults, Cliff" uniqKey="Shults C" first="Cliff" last="Shults">Cliff Shults</name>
</author>
<author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K." last="Wenning">Gregor K. Wenning</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0379937</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 03-0379937 INIST</idno>
<idno type="RBID">Pascal:03-0379937</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002478</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders</title>
<author><name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name>
<affiliation><inist:fA14 i1="01"><s1>Movement Disorder Program, University of Louisville, Bldg A Rm 113</s1>
<s2>Louisville, KY 40205</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Bhatia, Kailash P" sort="Bhatia, Kailash P" uniqKey="Bhatia K" first="Kailash P." last="Bhatia">Kailash P. Bhatia</name>
</author>
<author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
</author>
<author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E." last="Lang">Anthony E. Lang</name>
</author>
<author><name sortKey="Mckeith, Ian" sort="Mckeith, Ian" uniqKey="Mckeith I" first="Ian" last="Mckeith">Ian Mckeith</name>
</author>
<author><name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name>
</author>
<author><name sortKey="Sethi, Kapil D" sort="Sethi, Kapil D" uniqKey="Sethi K" first="Kapil D." last="Sethi">Kapil D. Sethi</name>
</author>
<author><name sortKey="Shults, Cliff" sort="Shults, Cliff" uniqKey="Shults C" first="Cliff" last="Shults">Cliff Shults</name>
</author>
<author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K." last="Wenning">Gregor K. Wenning</name>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Basal ganglion</term>
<term>Degeneration</term>
<term>Diagnosis</term>
<term>Human</term>
<term>Lewy body dementia</term>
<term>Multiple system atrophy</term>
<term>Parkinson disease</term>
<term>Progressive</term>
<term>Review</term>
<term>Supranuclear ophthalmoplegia</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Démence corps Lewy</term>
<term>Ophtalmoplégie supranucléaire</term>
<term>Progressif</term>
<term>Atrophie multisystématisée</term>
<term>Dégénérescence</term>
<term>Noyau gris central</term>
<term>Article synthèse</term>
<term>Diagnostic</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">As there are no biological markers for the antemortem diagnosis of degenerative parkinsonian disorders, diagnosis currently relies upon the presence and progression of clinical features and confirmation depends on neuropathology. Clinicopathologic studies have shown significant false-positive and false-negative rates for diagnosing these disorders, and misdiagnosis is especially common during the early stages of these diseases. It is important to establish a set of widely accepted diagnostic criteria for these disorders that may be applied and reproduced in a blinded fashion. This review summarizes the findings of the SIC Task Force for the study of diagnostic criteria for parkinsonian disorders in the areas of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, and corticobasal degeneration. In each of these areas, diagnosis continues to rest on clinical findings and the judicious use of ancillary studies.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>18</s2>
</fA05>
<fA06><s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>LITVAN (Irene)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>BHATIA (Kailash P.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BURN (David J.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>GOETZ (Christopher G.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>LANG (Anthony E.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>MCKEITH (Ian)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>QUINN (Niall)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>SETHI (Kapil D.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>SHULTS (Cliff)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>WENNING (Gregor K.)</s1>
</fA11>
<fA14 i1="01"><s1>Movement Disorder Program, University of Louisville, Bldg A Rm 113</s1>
<s2>Louisville, KY 40205</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA20><s1>467-486</s1>
</fA20>
<fA21><s1>2003</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000118200090010</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>143 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0379937</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>As there are no biological markers for the antemortem diagnosis of degenerative parkinsonian disorders, diagnosis currently relies upon the presence and progression of clinical features and confirmation depends on neuropathology. Clinicopathologic studies have shown significant false-positive and false-negative rates for diagnosing these disorders, and misdiagnosis is especially common during the early stages of these diseases. It is important to establish a set of widely accepted diagnostic criteria for these disorders that may be applied and reproduced in a blinded fashion. This review summarizes the findings of the SIC Task Force for the study of diagnostic criteria for parkinsonian disorders in the areas of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, and corticobasal degeneration. In each of these areas, diagnosis continues to rest on clinical findings and the judicious use of ancillary studies.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Démence corps Lewy</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Lewy body dementia</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Demencia cuerpos Lewy</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Ophtalmoplégie supranucléaire</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Supranuclear ophthalmoplegia</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Oftalmoplejía supranuclear</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Progressif</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Progressive</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Progresivo</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Atrophie multisystématisée</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Multiple system atrophy</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Atrofia multisistematizada</s0>
<s2>NM</s2>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Dégénérescence</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Degeneration</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Degeneración</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Noyau gris central</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Basal ganglion</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Núcleo basal</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Article synthèse</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Review</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Artículo síntesis</s0>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Diagnostic</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Diagnosis</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Diagnóstico</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Oeil pathologie</s0>
<s5>53</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Eye disease</s0>
<s5>53</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Ojo patología</s0>
<s5>53</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Oculomotricité syndrome</s0>
<s5>54</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Oculomotor syndrome</s0>
<s5>54</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Oculomotricidad síndrome</s0>
<s5>54</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Tronc cérébral syndrome</s0>
<s5>57</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Brain stem syndrome</s0>
<s5>57</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Tallo encefalico sindrome</s0>
<s5>57</s5>
</fC07>
<fN21><s1>265</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 03-0379937 INIST</NO>
<ET>SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders</ET>
<AU>LITVAN (Irene); BHATIA (Kailash P.); BURN (David J.); GOETZ (Christopher G.); LANG (Anthony E.); MCKEITH (Ian); QUINN (Niall); SETHI (Kapil D.); SHULTS (Cliff); WENNING (Gregor K.)</AU>
<AF>Movement Disorder Program, University of Louisville, Bldg A Rm 113/Louisville, KY 40205/Etats-Unis (1 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2003; Vol. 18; No. 5; Pp. 467-486; Bibl. 143 ref.</SO>
<LA>Anglais</LA>
<EA>As there are no biological markers for the antemortem diagnosis of degenerative parkinsonian disorders, diagnosis currently relies upon the presence and progression of clinical features and confirmation depends on neuropathology. Clinicopathologic studies have shown significant false-positive and false-negative rates for diagnosing these disorders, and misdiagnosis is especially common during the early stages of these diseases. It is important to establish a set of widely accepted diagnostic criteria for these disorders that may be applied and reproduced in a blinded fashion. This review summarizes the findings of the SIC Task Force for the study of diagnostic criteria for parkinsonian disorders in the areas of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy, multiple system atrophy, and corticobasal degeneration. In each of these areas, diagnosis continues to rest on clinical findings and the judicious use of ancillary studies.</EA>
<CC>002B17G</CC>
<FD>Parkinson maladie; Démence corps Lewy; Ophtalmoplégie supranucléaire; Progressif; Atrophie multisystématisée; Dégénérescence; Noyau gris central; Article synthèse; Diagnostic; Homme</FD>
<FG>Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Oeil pathologie; Oculomotricité syndrome; Tronc cérébral syndrome</FG>
<ED>Parkinson disease; Lewy body dementia; Supranuclear ophthalmoplegia; Progressive; Multiple system atrophy; Degeneration; Basal ganglion; Review; Diagnosis; Human</ED>
<EG>Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Eye disease; Oculomotor syndrome; Brain stem syndrome</EG>
<SD>Parkinson enfermedad; Demencia cuerpos Lewy; Oftalmoplejía supranuclear; Progresivo; Atrofia multisistematizada; Degeneración; Núcleo basal; Artículo síntesis; Diagnóstico; Hombre</SD>
<LO>INIST-20953.354000118200090010</LO>
<ID>03-0379937</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002478 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002478 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:03-0379937
   |texte=   SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri